Yield10 Bioscience Announces Second Quarter 2024 Financial Results

WOBURN, Mass., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) ("Yield10" or the "Company"), an agricultural bioscience company, today reported financial results for the second quarter ended June 30, 2024.

Yield10 Bioscience Grants Nufarm a Commercial License to Omega-3 Assets for Producing Oil in Camelina, and Yield10 and Nufarm sign a Memorandum of Understanding for Sale of Assets

Yield10 Bioscience Grants Nufarm a Commercial License to Omega-3 Assets for Producing Oil in Camelina.

Yield10 Bioscience Announces Addition of Camelina to INTERLINE® Herbicide Label

- EPA approved an amendment to the label of INTERLINE herbicideto include Camelina

Yield10 Bioscience, Inc. 2023 Q4 - Results - Earnings Call Presentation

Yield10 Bioscience, Inc. (YTEN) Q4 2023 Earnings Call Transcript